Chargement en cours...
Autoimmune Encephalitis After Treatment of Hodgkin’s Lymphoma with the Immune Checkpoint Inhibitor Nivolumab
In recent years, by the usage of new immune therapeutic agents for cancer treatment, the neurologic adverse events began to be seen more frequently. Nivolumab, one of the immune checkpoint inhibitor, is a human IgG4 antibody that blocks programmed cell death protein 1 and is approved against metasta...
Enregistré dans:
| Publié dans: | Noro Psikiyatr Ars |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Noro-Psikiyatri Arsivi
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8214751/ https://ncbi.nlm.nih.gov/pubmed/34188600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.29399/npa.23353 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|